Modulation of energy metabolism is emerging as a key aspect associated with cell fate transition. The establishment of a correct metabolic program is particularly relevant for neural cells given their high bioenergetic requirements. Accordingly, diseases of the nervous system commonly involve mitochondrial impairment. Recent studies in animals and in neural derivatives of human pluripotent stem cells (PSCs) highlighted the importance of mitochondrial metabolism for neural fate decisions in health and disease. The mitochondriabased metabolic program of early neurogenesis suggests that PSC-derived neural stem cells (NSCs) may be used for modeling neurological disorders. Understanding how metabolic programming is orchestrated during neural commitment may provide important information for the development of therapies against conditions affecting neural functions, including aging and mitochondrial disorders.
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Within the nervous system, stem cells need to generate both neurons and glia [1] [2] [3] . Their derivation -collectively defined here as neurogenesis -requires the careful orchestration of cell type-specific epigenetic signatures. These signatures may be influenced by the metabolic state of the cells, given that metabolites can act as epigenetic regulators [4] . At the same time, the transcriptional reorganization associated with neural specification generates distinct metabolic programs that may also be cell type-specific and may in turn contribute to the correct establishment of the needed cellular identity.
Here, we discuss recent literature addressing how the metabolic programs of neurons and glia are constructed. The works have been conducted both in animals and in neural derivatives of human pluripotent stem cells (PSCs). It is important to point out that the generation of neural cells in vitro can be influenced by the culture conditions, including signaling molecules and oxygen levels [5] . Therefore, the metabolism of in vitro derived human neural cells may not necessarily mirror that of the actual neural cells residing in the human brain. Nonetheless, the use of human PSC neural derivatives is allowing for the first time to investigate the metabolic regulation of human brain cells.
Some of the recent findings that we will discuss here, generated from in vivo and in vitro experiments, have challenged the conventional idea associated with the metabolic remodeling of neurogenesis. The picture emerging is that metabolism is more plastic than previously expected and that it can be fine-tuned at different levels during neural commitment. We also comment on clinically relevant opportunities that are starting to be translated from these basic studies. We believe that this renewed interest in the metabolic contribution to neural specification may bring important insights for the study of diseases affecting the nervous system, including neurodegeneration and mitochondrial disorders.
Glycolytic metabolism and neurogenesis
The metabolic programs of neurons and glia are considered to be very divergent.
Neurons are dependent on mitochondrial-based oxidative phosphorylation (OXPHOS) while glia rely on glycolysis [6, 7] . Both cell types are generated from multipotent neural stem cells (NSCs), which appear to share some of the features of glial cells, including the reliance on glycolytic metabolism [2, 8] . Given that the modulation of metabolism may be instrumental during neural commitment [9] , it becomes critical to investigate how the cell type-specific metabolic programs are regulated.
The glycolytic nature of NSCs is usually explained by the fact that glycolysis is the preferred metabolic route of stemness [10] . Accordingly, PSC-derived neural progenitor cells The picture becomes more complicated when we consider the proliferative rate of stem cells. In the case of PSCs, for example, the glycolytic metabolism is suggested to be a consequence of their elevated level of proliferation [13, 14] . Highly proliferative cells like cancer cells prefer indeed glycolysis, since it provides the precursor molecules for biomass generation via the pentose phosphate pathway (PPP) that emerges from the upstream branches of glycolysis [15] . In the case of hematopoietic stem cells (HCS), however, glycolysis is considered to be chosen over OXPHOS due to the fact that HSCs do not actively proliferate and therefore do not have high bioenergetic needs [16, 17] . These findings raise the question of why stem cells would prefer glycolysis regardless of their rate of proliferation. The relationship between proliferation and stem cell metabolism may be particularly important in the context of the nervous system. NSCs in vivo can in fact rapidly divide during development but become quiescent in adult age [18] . The induction of glycolysis in NSCs might also be influenced by the level of oxygen and by the activation of hypoxia inducible factors (HIFs) [25] . This was found to be the case in the context of PSCs [26, 27] . The oxygen sensing response can in fact be controlled by cellular ROS rather than by OXPHOS metabolism per se [28] . Nevertheless, the glycolytic metabolic state of ex vivo mouse NSCs has been found to be not dependent on HIFs [29] . At the same time, HIFs may be important in the in vitro derivation of NPCs from human PSCs, as the level of oxygen has been suggested to modulate whether NPCs can differentiate more efficiently into neurons or glia [30] . Therefore, the importance of HIF-mediated response in neurogenesis requires further investigations.
Another possibility for explaining the reliance on glycolysis of NSCs and glia and the reliance on OXPHOS in the case of neurons may be that these metabolic programs may 6 contribute to the epigenetic regulation of the respective cell fate. The process of establishing a cell fate identity requires a complex integration between environmental cues and transcriptional states [13] . In this scenario, cellular metabolism may represent the mechanism through which a cell responds to both exogenous stimuli and gene expression programs [4] .
Within the complex regulation of epigenetics during neural cell commitment [31] , however, the importance of metabolism still remains largely unexplored.
Mitochondrial metabolism and dynamics during neurogenesis
An important aspect that has been recently challenged of the classical view of metabolism in neurogenesis relates to the time point in which the oxidative metabolic program is activated and to the respective morphology of mitochondria.
As mentioned above, the NSC state is believed to be linked with glycolytic metabolism coupled to non-fused mitochondrial morphology, which is considered typical for glycolytic stem cells [32] . In the neural lineage, OXPHOS metabolism is usually associated only with differentiated neurons [7, 33] The apparent disagreement of these latter findings with other published works on PSCderived NPCs [11, 12] , may perhaps be explained by the type of signaling molecules used for the derivation of NPCs in vitro. Glycolytic NPCs were cultivated using basal FGF [11], which may be per se associated with enhanced glycolysis [40] . Conversely, oxidative NPCs were grown with LIF [39], which promotes mitochondrial metabolism [41] . Collectively, these data indicate that activation of the OXPHOS program during neurogenesis may occur earlier than expected [42] and that it may be influenced by signaling and environmental cues (Figure 1 ).
This novel concept of how metabolic programs are orchestrated during neural commitment underscores the metabolic plasticity associated with the cell fate transitions. In this emerging picture, it will be relevant to dissect the state of mitochondrial metabolism and dynamics of glia cells. Astrocytes are considered to be dependent on glycolytic metabolism, as they can produce glycolysis-derived lactate that is then secreted and used to fuel neurons [6] . Oligodendrocytes also rely on glycolysis [43] , further supporting the metabolic compartmentalization of the central nervous system. Nonetheless, the lactate produced by astrocytes and oligodendrocytes can also be obtained from pyruvate generated from malate coming from the mitochondrial tricarboxylic acid (TCA) cycle [44] . Hence, mitochondrial metabolism might also be potentially relevant for glial cells. Accordingly, glioblastoma cells forced to increase OXPHOS and mitochondrial biogenesis efficiently differentiate into astrocytes [45] .
Understanding the relevance of mitochondria for glia cells might be important for facilitating the reprogramming of astrocytes into neurons [46] , given that metabolism represents a critical roadblock in this process [47] . The investigation of astrocytic mitochondria may also provide essential clues to explain the phenomenon of mitochondrial 8 transfer between astrocytes and neurons that has been reported to occur in vivo in mice following ischemic insults [48] .
Targeting mitochondria for improving neurogenesis in neurological diseases
Mitochondrial defects are a known pathogenetic mechanism involved in conditions causing neurological impairment, including aging-associated neurodegeneration The findings also suggest that iPSC-derived NPCs may represent a viable model for investigating neurological diseases. NPCs from patients affected by schizophrenia have been found to exhibit disease-associated phenotypes [54] . The use of NPCs may particularly be important for mitochondrial disorders that are caused by mutations in the mitochondrial DNA (mtDNA) and for which there is a lack of viable modeling systems [55] . iPSC-derived NPCs from patients affected by Leigh syndrome carrying a mtDNA mutation in the gene MT-ATP6 have been used for the establishment of a drug discovery platform [39] . Leigh syndrome NPCs displayed a defect in calcium homeostasis that was observed in neurons but not in other peripheral cells [39] . The observed NPC defects might imply that Leigh syndrome also affects 9 neurogenesis. Interestingly, hypoxia stimulation was recently shown to significantly improve the life-span of a mouse model of Leigh syndrome [56] . The mechanisms underlying the beneficial effect of hypoxia in the Leigh syndrome mice remain unclear. However, given the above-mentioned importance of redox metabolism and HIFs signaling for NSCs and their glycolytic state, it is perhaps possible that hypoxic exposure may be beneficial to Leigh syndrome mice because it promotes NSC proliferation and neurogenesis.
In conclusion, the recent data addressing how the metabolic programs of neural cells are 
